About this FactMed analysis covering adverse side effect reports of ACAI patients who developed DYSPEPSIA.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 1 individuals taking ACAI reported DYSPEPSIA to the FDA. A total of 25 ACAI drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ACAI and DYSPEPSIA. In doing so, we compare ACAI with other drugs that cause DYSPEPSIA, to help you evaluate whether or not ACAI causes DYSPEPSIA. Likewise, this page shows the most highly-reported side effects of ACAI, so you can see if DYSPEPSIA ranks among ACAI's most well-known side effects.
Summary Statistics
Reports of ACAI causing DYSPEPSIA: 1
Reports of any side effect of ACAI : 25
Percentage of ACAI patients where DYSPEPSIA is a reported side effect: 4.0000%

FDA reports of any drug causing DYSPEPSIA : 27791
Average percentage for all medicated patients where DYSPEPSIA is reported as a complication: 0.1742%

Physician opinion on ACAI as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ACAI:
VITAMIN SUPPLEMENTATION ( 6 patients )
DRUG USE FOR UNKNOWN INDICATION ( 3 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 2 patients )
MEDICAL DIET ( 1 patients )
ROUTINE HEALTH MAINTENANCE ( 1 patients )
SUPPLEMENTATION THERAPY ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with DYSPEPSIA:

NEXIUM (4341 patients)
VIOXX (4237 patients)
FOSAMAX (3527 patients)
ASPIRIN (2618 patients)
BYETTA (1689 patients)
PRADAXA (1479 patients)
LIPITOR (1327 patients)
PRILOSEC (1314 patients)
SYNTHROID (1125 patients)
YAZ (1072 patients)
OMEPRAZOLE (1041 patients)
YASMIN (981 patients)
LISINOPRIL (907 patients)
ACCUTANE (877 patients)
ZOLOFT (857 patients)
PREDNISONE (853 patients)
CELEBREX (831 patients)
PROTONIX (821 patients)
SEROQUEL (809 patients)
PREVACID (797 patients)
XANAX (787 patients)
ATENOLOL (787 patients)
ZOMETA (781 patients)
CHANTIX (756 patients)
IBUPROFEN (754 patients)
METFORMIN HCL (753 patients)
LASIX (739 patients)
NEURONTIN (720 patients)
NORVASC (715 patients)
AMBIEN (712 patients)
BONIVA (697 patients)
PLAVIX (696 patients)
SIMVASTATIN (686 patients)
ZOCOR (683 patients)
CRESTOR (675 patients)
HYDROCHLOROTHIAZIDE (641 patients)
ZANTAC (635 patients)
PAXIL (633 patients)
COUMADIN (624 patients)
TOPROL-XL (622 patients)
ALBUTEROL (610 patients)
FORTEO (610 patients)
AREDIA (592 patients)
OXYCONTIN (580 patients)
FUROSEMIDE (549 patients)
VITAMIN D (542 patients)
DIOVAN (517 patients)
LEXAPRO (515 patients)
PREMARIN (514 patients)
HUMIRA (512 patients)
ACETAMINOPHEN (511 patients)
GLUCOPHAGE (510 patients)
FOLIC ACID (507 patients)
VICODIN (496 patients)
LANTUS (489 patients)
NIASPAN (481 patients)
CYMBALTA (465 patients)
LEVOTHYROXINE SODIUM (459 patients)
ATIVAN (456 patients)
METHOTREXATE (449 patients)
DIGOXIN (443 patients)
LYRICA (443 patients)
PERCOCET (436 patients)
SINGULAIR (419 patients)
LORAZEPAM (415 patients)
ADVAIR DISKUS 100/50 (412 patients)
CALCIUM (409 patients)
ENBREL (400 patients)
PROZAC (397 patients)
LEVAQUIN (395 patients)
ACTONEL (382 patients)
LORTAB (377 patients)
VITAMIN E (373 patients)
GABAPENTIN (366 patients)
ASCORBIC ACID (362 patients)
MULTI-VITAMIN (355 patients)
FISH OIL (355 patients)
ZYRTEC (354 patients)
SPIRIVA (352 patients)
ACIPHEX (345 patients)
ALPRAZOLAM (337 patients)
ACTOS (336 patients)
POTASSIUM CHLORIDE (334 patients)
AMOXICILLIN (332 patients)
KLONOPIN (332 patients)
METOPROLOL TARTRATE (332 patients)
WELLBUTRIN (331 patients)
LEVOXYL (331 patients)
TYLENOL (328 patients)
CALCIUM CARBONATE (328 patients)
EFFEXOR (325 patients)
ALLOPURINOL (323 patients)
FOSAMAX PLUS D (319 patients)
ALLEGRA (314 patients)
PREDNISONE TAB (314 patients)
NITROGLYCERIN (313 patients)
CELEXA (313 patients)
ZOFRAN (311 patients)
TYLENOL (CAPLET) (311 patients)
METFORMIN (306 patients)
GLIPIZIDE (302 patients)
SANDOSTATIN LAR (299 patients)
GLYBURIDE (298 patients)
ZETIA (296 patients)
OXYCODONE HCL (295 patients)
RANITIDINE (294 patients)
DROSPIRENONE AND ETHINYL ESTRADIOL (292 patients)
MULTI-VITAMINS (291 patients)
BEXTRA (291 patients)
CLONAZEPAM (291 patients)
ALEVE (290 patients)
AVONEX (288 patients)
ALENDRONATE SODIUM (288 patients)
PRILOSEC OTC (282 patients)
AVANDIA (282 patients)
SUTENT (279 patients)
ALEVE (CAPLET) (279 patients)
METOPROLOL (277 patients)
PEPCID (275 patients)
AMARYL (270 patients)
MORPHINE (270 patients)
DURAGESIC-100 (268 patients)
FLEXERIL (267 patients)
INSULIN (266 patients)
[THERAPY UNSPECIFIED] (265 patients)
NAPROXEN (264 patients)
DEXAMETHASONE (262 patients)
COMMIT (261 patients)
VICTOZA (258 patients)
COREG (254 patients)
TRAZODONE HCL (254 patients)
ZITHROMAX (254 patients)
TRAMADOL HCL (254 patients)
VALIUM (251 patients)
DECADRON (241 patients)
HEPARIN SODIUM INJECTION (240 patients)
REMICADE (239 patients)
NEXAVAR (235 patients)
KEFLEX (235 patients)
CLONIDINE (234 patients)
REGLAN (231 patients)
ZYPREXA (230 patients)
LANSOPRAZOLE (229 patients)
AMLODIPINE (229 patients)
CALCIUM (UNSPECIFIED) (227 patients)
COZAAR (223 patients)
CLARITIN (222 patients)
CEPHALEXIN (222 patients)
DIAZEPAM (222 patients)
FLOMAX (221 patients)
FENTANYL (220 patients)
SPIRONOLACTONE (220 patients)
PANTOPRAZOLE (218 patients)
HUMALOG (215 patients)
CIPROFLOXACIN (214 patients)
PROMETHAZINE (210 patients)
VITAMINS (UNSPECIFIED) (208 patients)
PRAVACHOL (206 patients)
VITAMIN B-12 (205 patients)
THALIDOMIDE (205 patients)
BENADRYL (199 patients)
XELODA (198 patients)
AZITHROMYCIN (198 patients)
DILAUDID (197 patients)
MOTRIN (195 patients)
CIALIS (194 patients)
EVISTA (194 patients)
HYDROCODONE BITARTRATE (194 patients)
FLONASE (193 patients)
REVLIMID (192 patients)
TRICOR (192 patients)
SYMBICORT (192 patients)
AVELOX (191 patients)
VIAGRA (190 patients)
LOVAZA (190 patients)
TYLENOL-500 (189 patients)
POTASSIUM (188 patients)
TYSABRI (187 patients)
COMPAZINE (186 patients)
WARFARIN SODIUM (185 patients)
LOTREL (185 patients)
ACYCLOVIR (185 patients)
FLUOXETINE (185 patients)
TEGRETOL (184 patients)
ZANTAC 150 (183 patients)
ELAVIL (180 patients)
LOVENOX (180 patients)
ARIMIDEX (180 patients)
DOXYCYCLINE (180 patients)
TOPAMAX (179 patients)
HYDROCODONE (179 patients)
ULTRAM (179 patients)
ALTACE (178 patients)
METOCLOPRAMIDE (176 patients)
VALTREX (176 patients)
CLINDAMYCIN (175 patients)
EXJADE (173 patients)
GLEEVEC (173 patients)
EFFEXOR XR (173 patients)
VELCADE (172 patients)
LIDOCAINE (171 patients)
MOBIC (171 patients)
GLUCOSAMINE (170 patients)
TEMAZEPAM (170 patients)
STRATTERA (168 patients)
DIFLUCAN (168 patients)
MIRALAX (168 patients)
VYTORIN (168 patients)
PREDNISOLONE (167 patients)
GLUCOTROL (166 patients)
Most common side effects for patients taking ACAI:
RENAL FAILURE ACUTE (6 patients)
ATRIOVENTRICULAR BLOCK SECOND DEGREE (5 patients)
FALL (5 patients)
NEUROPATHY PERIPHERAL (4 patients)
MEMORY IMPAIRMENT (3 patients)
WEIGHT DECREASED (3 patients)
MUSCLE TWITCHING (3 patients)
FATIGUE (3 patients)
VISUAL ACUITY REDUCED (3 patients)
BALANCE DISORDER (3 patients)
STRESS (3 patients)
EXCORIATION (3 patients)
ERYTHEMA (3 patients)
COGNITIVE DISORDER (3 patients)
COORDINATION ABNORMAL (3 patients)
PAIN (3 patients)
DEHYDRATION (3 patients)
DERMATITIS INFECTED (2 patients)
PRODUCT ADHESION ISSUE (2 patients)
PAIN IN EXTREMITY (2 patients)
RASH (2 patients)
ONYCHOCLASIS (2 patients)
DRY SKIN (2 patients)
ONYCHALGIA (2 patients)
CARPAL TUNNEL SYNDROME (2 patients)
ROTATOR CUFF REPAIR (2 patients)
ROTATOR CUFF SYNDROME (2 patients)
EXOSTOSIS (2 patients)
TRANSITIONAL CELL CARCINOMA (2 patients)
VISUAL IMPAIRMENT (2 patients)
NAUSEA (2 patients)
GASTROENTERITIS VIRAL (2 patients)
NASOPHARYNGITIS (2 patients)
HOT FLUSH (2 patients)
VOMITING (2 patients)
LIMB CRUSHING INJURY (2 patients)
INCISION SITE HAEMORRHAGE (2 patients)
LOWER EXTREMITY MASS (2 patients)
INSOMNIA (1 patients)
KIDNEY INFECTION (1 patients)
ABDOMINAL PAIN (1 patients)
INFLUENZA LIKE ILLNESS (1 patients)
HYPONATRAEMIA (1 patients)
MONOPLEGIA (1 patients)
MULTI-ORGAN FAILURE (1 patients)
MULTIPLE SCLEROSIS RELAPSE (1 patients)
HYPERTENSION (1 patients)
MYALGIA (1 patients)
HERPES ZOSTER (1 patients)
FEELING HOT (1 patients)
EAR INFECTION (1 patients)
NEUTROPENIA (1 patients)
NON-HODGKIN'S LYMPHOMA (1 patients)
DYSPEPSIA (1 patients)
DRUG INEFFECTIVE (1 patients)
OROPHARYNGEAL PAIN (1 patients)
DIZZINESS (1 patients)
DIVERTICULITIS (1 patients)
PHARYNGITIS (1 patients)
DIARRHOEA (1 patients)
PYREXIA (1 patients)
CYSTITIS (1 patients)
RENAL CYST (1 patients)
BLOOD TRIGLYCERIDES INCREASED (1 patients)
RHEUMATOID ARTHRITIS (1 patients)
BLOOD PRESSURE INCREASED (1 patients)
BLADDER DISORDER (1 patients)
SHOCK (1 patients)
SKIN LACERATION (1 patients)
STAPHYLOCOCCAL INFECTION (1 patients)
BLADDER CANCER (1 patients)
SYSTEMIC LUPUS ERYTHEMATOSUS (1 patients)
BASAL CELL CARCINOMA (1 patients)
URTICARIA (1 patients)
UVEITIS (1 patients)
ASTHENIA (1 patients)
ARTHRALGIA (1 patients)
ACUTE RESPIRATORY DISTRESS SYNDROME (1 patients)
ACUTE HEPATIC FAILURE (1 patients)
WOUND INFECTION (1 patients)
WRONG TECHNIQUE IN DRUG USAGE PROCESS (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for ACAI


Issue Description / Topic Timestamp
QUESTION
BURNING SENSATION
I have not taken acai berry but have experienced a burning sensation and a tingling "pins and needles" sensation from taking maqui berry capsules. There is very little research on humans on maqui berry's side effects. I am wondering if anyone else has experienced similar. M 2017-05-09 17:39:37

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about DYSPEPSIA and ACAI, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ACAI, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ACAI. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ACAI experts. If you are a healthcare provider experienced in prescribing ACAI, please register here.
giCould not connect: